Saturday, January 31, 2026
26.3 C
Bengaluru

An Infectious Disease Specialist Speaks to Pharma on How it Needs to Change its Approach

linkedin.com/in/dr-mandar-kubal-3721352

Key Point from the Q &A with Dr. Mandar Kubal, Mumbai

Telemedicine has become a very useful tool for clinicians to manage their patients.

Given the ever changing contours of Covid19 treatment, doctors have to check daily for online resources.

It would be wonderful if pharma can provide every specialty the latest developments in treating Covid19 with pre existing conditions instead of sending their unvaccinated field force to give brand reminders.

Pharma should seek frontline worker status for Medical Reps and Field Managers as they are critical to maintain the drug supply chain.

Treat the Field Force as an asset and protect them, instead of pushing them onto the field without vaccination.

And many more insights from a clinician at the frontlines of treating Covid19 patients.

An Infectious Disease Specialist Speaks to Pharma on How it Needs to Change its Approach @YouTube

………………………………………………………………………………………………………………………….

Digital Excellence Pharma Academy (DEPA) begins a new series of conversations with doctors to Indian Pharma and insight into their challenges and how pharma needs to change its current approach to interactions with doctors

Great Opportunity for Pharma People to Listen to What Doctors have to Say https://youtu.be/wqCK574qb-g
Conversation with Dr. Deepak Krishnamurthy on Expectations of Doctors from Pharma https://youtu.be/7VVzhMlY2Uw

You can also listen to what pharma leaders from across the globe have to say about various aspects of pharma’s challenges and solutions on MedicinMan YouTube Channel – https://www.youtube.com/channel/UCEj-fkwCUJGVW0-FmipRP3A

Hot this week

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead

The latest PharmaTrac report for December 2025 offers a...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Topics

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Zydus vs. Helsinn — What It Really Means for Indian Pharma

On December 24, 2025, the Delhi High Court delivered...

Worldclass Healthcare But Out of Reach for Most Indians?

When an eminent cardiologist like Dr. Sunil Chandy—former Director...

Managed Healthcare – Better Choice for India?

Managed care shifts healthcare from fragmented fee-for-service models to...
spot_img

Related Articles

spot_imgspot_img